Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524025 · ClinicalTrials.gov registry record
The SPOT-HPV Study
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 360
- Enrollment target
NCT05524025 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 360 participants.
The verdict
NCT05524025 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 360 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate a new test for oral HPV DNA in saliva ('oral rinse test').
Interventions
- DIAGNOSTIC_TEST Salivary TTMV-HPV DNA Test
- DIAGNOSTIC_TEST Blood TTMV-HPV DNA Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2026-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05524025
The ClinicalTrials.gov registry entry for NCT05524025 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Salivary TTMV-HPV DNA Test is the first listed.
NCT05524025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05524025 about?
NCT05524025 is a clinical study titled "The SPOT-HPV Study". The purpose of this research is to evaluate a new test for oral HPV DNA in saliva ('oral rinse test').
What is the current status of trial NCT05524025?
This trial is currently completed. The enrollment target is 360 participants. The study started on 2022-11-30. Estimated completion is 2026-01-01.
What interventions are being tested in trial NCT05524025?
The interventions under investigation include: Salivary TTMV-HPV DNA Test (DIAGNOSTIC_TEST), Blood TTMV-HPV DNA Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05524025?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.